Oyster Point Pharma to Present Data at the American Academy of Ophthalmology Annual Meeting 2021

Oyster Point Pharma announced multiple scientific presentations at the American Academy of Ophthalmology (AAO) annual meeting 2021 being held in New Orleans, November 12–15, 2021.

“The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons whose mission is to empower lives by serving as an advocate for patients and the public, leading ophthalmic education, and advancing the profession of ophthalmology,” Marian Macsai, MD Chief Medical Officer of Oyster Point Pharma, said in a company news release. “We are pleased to share a number of data presentations from company-sponsored clinical trials at this year’s meeting highlighting the recently approved Tyrvaya (varenicline solution) Nasal Spray for the treatment of the signs and symptoms of dry eye disease.”

Papers/Posters

Title: ONSET-2 Phase 3 Trial of OC-01 (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease 
Presenter: Marjan Farid, MD
Location: Morial Convention Center, Room 255-257
Presentation Date/time: November 14 at 8:48am–8:55am CST

Title: OC-01 Nasal Spray Clinical Sign Outcomes in Dry Eye Disease by Baseline Stratification Factors - Combined ONSET-1 & -2 
Presenter: John D Sheppard MD
Location: Morial Convention Center, Hall C (Poster Theater and Lounge)
Presentation Date/Time: November 14 at 3:45-4:45 pm CST

Title: OC-01 (varenicline solution) Nasal Spray Clinical Sign Outcomes in Dry Eye Disease by Age and Artificial Tear Use – A Subgroup Analysis 
Presenter: Alice T. Epitropoulos, MD
Location: Virtual
Presentation Date/Time: On Demand